Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asnaghi, V.
Right arrow Articles by Lorenzi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asnaghi, V.
Right arrow Articles by Lorenzi, M.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:506-511, 2003
© 2003 by the American Diabetes Association, Inc.

A Role for the Polyol Pathway in the Early Neuroretinal Apoptosis and Glial Changes Induced by Diabetes in the Rat

Veronica Asnaghi, Chiara Gerhardinger, Todd Hoehn, Abidemi Adeboje, and Mara Lorenzi

From the Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts

We tested the hypothesis that the apoptosis of inner retina neurons and increased expression of glial fibrillary acidic protein (GFAP) observed in the rat after a short duration of diabetes are mediated by polyol pathway activity. Rats with 10 weeks of streptozotocin-induced diabetes and GHb levels of 16 ± 2% (mean ± SD) showed increased retinal levels of sorbitol and fructose, attenuation of GFAP immunostaining in astrocytes, appearance of prominent GFAP expression in Müller glial cells, and a fourfold increase in the number of apoptotic neurons when compared with nondiabetic rats. The cells undergoing apoptosis were immunoreactive for aldose reductase. Sorbinil, an inhibitor of aldose reductase, prevented all abnormalities. Intensive insulin treatment also prevented most abnormalities, despite reducing GHb only to 12 ± 1%. Diabetic mice, known to have much lower aldose reductase activity in other tissues when compared with rats, did not accumulate sorbitol and fructose in the retina and were protected from neuronal apoptosis and GFAP changes in the presence of GHb levels of 14 ± 2%. This work documents discrete cellular consequences of polyol pathway activity in the retina, and it suggests that activation of the pathway and "retinal neuropathy" require severe hyperglycemia and/or high activity of aldose reductase. These findings have implications for how to evaluate the role of the polyol pathway in diabetic retinopathy.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Physiol.Home page
T. S. Kern and A. J. Barber
Retinal ganglion cells in diabetes
J. Physiol., September 15, 2008; 586(18): 4401 - 4408.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. J. Gastinger, A. R. Kunselman, E. E. Conboy, S. K. Bronson, and A. J. Barber
Dendrite Remodeling and Other Abnormalities in the Retinal Ganglion Cells of Ins2Akita Diabetic Mice
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2635 - 2642.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. K. Ali, S. Matragoon, B. A. Pillai, G. I. Liou, and A. B. El-Remessy
Peroxynitrite Mediates Retinal Neurodegeneration by Inhibiting Nerve Growth Factor Survival Signaling in Experimental and Human Diabetes
Diabetes, April 1, 2008; 57(4): 889 - 898.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
T Oshitari, S Yamamoto, N Hata, and S Roy
Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy
Br. J. Ophthalmol., April 1, 2008; 92(4): 552 - 556.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Kusari, S. Zhou, E. Padillo, K. G. Clarke, and D. W. Gil
Effect of Memantine on Neuroretinal Function and Retinal Vascular Changes of Streptozotocin-Induced Diabetic Rats
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5152 - 5159.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. Carrasco, C. Hernandez, A. Miralles, P. Huguet, J. Farres, and R. Simo
Lower Somatostatin Expression Is an Early Event in Diabetic Retinopathy and Is Associated With Retinal Neurodegeneration
Diabetes Care, November 1, 2007; 30(11): 2902 - 2908.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
W. Sun, P. J. Oates, J. B. Coutcher, C. Gerhardinger, and M. Lorenzi
A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Diabetes, October 1, 2006; 55(10): 2757 - 2762.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. R. Santiago, S. C. Rosa, P. F. Santos, A. J. Cristovao, A. J. Barber, and A. F. Ambrosio
Elevated glucose changes the expression of ionotropic glutamate receptor subunits and impairs calcium homeostasis in retinal neural cells.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4130 - 4137.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. S. Ola, D. A. Berkich, Y. Xu, M. T. King, T. W. Gardner, I. Simpson, and K. F. LaNoue
Analysis of glucose metabolism in diabetic rat retinas
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1057 - E1067.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. B. El-Remessy, M. Al-Shabrawey, Y. Khalifa, N.-T. Tsai, R. B. Caldwell, and G. I. Liou
Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
Am. J. Pathol., January 1, 2006; 168(1): 235 - 244.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
W. Sun, C. Gerhardinger, Z. Dagher, T. Hoehn, and M. Lorenzi
Aspirin at Low-Intermediate Concentrations Protects Retinal Vessels in Experimental Diabetic Retinopathy Through Non-Platelet-Mediated Effects
Diabetes, December 1, 2005; 54(12): 3418 - 3426.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. A. Feit-Leichman, R. Kinouchi, M. Takeda, Z. Fan, S. Mohr, T. S. Kern, and D. F. Chen
Vascular Damage in a Mouse Model of Diabetic Retinopathy: Relation to Neuronal and Glial Changes
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4281 - 4287.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. K.H. Cheung, M. K.L. Fung, A. C.Y. Lo, T. T.L. Lam, K. F. So, S. S.M. Chung, and S. K. Chung
Aldose Reductase Deficiency Prevents Diabetes-Induced Blood-Retinal Barrier Breakdown, Apoptosis, and Glial Reactivation in the Retina of db/db Mice
Diabetes, November 1, 2005; 54(11): 3119 - 3125.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C. J. Layton, G. Chidlow, R. J. Casson, J. P. M. Wood, M. Graham, and N. N. Osborne
Monocarboxylate Transporter Expression Remains Unchanged during the Development of Diabetic Retinal Neuropathy in the Rat
Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2878 - 2885.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. J. Barber, D. A. Antonetti, T. S. Kern, C. E. N. Reiter, R. S. Soans, J. K. Krady, S. W. Levison, T. W. Gardner, and S. K. Bronson
The Ins2Akita Mouse as a Model of Early Retinal Complications in Diabetes
Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2210 - 2218.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. K. Srivastava, K. V. Ramana, and A. Bhatnagar
Role of Aldose Reductase and Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic Options
Endocr. Rev., May 1, 2005; 26(3): 380 - 392.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. A.F. Sima and Z.-g. Li
The Effect of C-Peptide on Cognitive Dysfunction and Hippocampal Apoptosis in Type 1 Diabetic Rats
Diabetes, May 1, 2005; 54(5): 1497 - 1505.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Jauniaux, J. Hempstock, C. Teng, F. C. Battaglia, and G. J. Burton
Polyol Concentrations in the Fluid Compartments of the Human Conceptus during the First Trimester of Pregnancy: Maintenance of Redox Potential in a Low Oxygen Environment
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1171 - 1175.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C. Gerhardinger, M. B. Costa, M. C. Coulombe, I. Toth, T. Hoehn, and P. Grosu
Expression of Acute-Phase Response Proteins in Retinal Muller Cells in Diabetes
Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 349 - 357.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
P. M. Martin, P. Roon, T. K. Van Ells, V. Ganapathy, and S. B. Smith
Death of Retinal Neurons in Streptozotocin-Induced Diabetic Mice
Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3330 - 3336.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Z. Dagher, Y. S. Park, V. Asnaghi, T. Hoehn, C. Gerhardinger, and M. Lorenzi
Studies of Rat and Human Retinas Predict a Role for the Polyol Pathway in Human Diabetic Retinopathy
Diabetes, September 1, 2004; 53(9): 2404 - 2411.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. L. Kusner, V. P. Sarthy, and S. Mohr
Nuclear Translocation of Glyceraldehyde-3-Phosphate Dehydrogenase: A Role in High Glucose-Induced Apoptosis in Retinal Muller Cells
Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1553 - 1561.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.